UCLA Medical Center: Division of Rheumatology

Los Angeles, California 90095

1 studies enrolling now · 7 studies all time

What they study most

Diffuse Cutaneous Systemic Sclerosis, Healthy Participants, Juvenile Dermatomyositis (JDM), Juvenile Idiopathic Arthritis (JIA), Lupus, Lupus Nephritis, Multiple Sclerosis (MS), Pediatric SLE, Pediatric-Onset Multiple Sclerosis (POMS), Pemphigus Vulgaris, Rheumatoid Arthritis (RA), Rheumatoid Arthritis (RA) Prevention

Studies at this site

• VIBRANT: VIB4920 for Active Lupus Nephritis — Recruiting now
• COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders — Stopped early
• JBT-101 in Systemic Lupus Erythematosus (SLE) — Completed
• Brentuximab Vedotin for Systemic Sclerosis — Completed
• Examining Distinct Immunophenotypes to Validate and Enhance Rational Treatment in Systemic Lupus — Stopped early
• Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis — Stopped early
• Rituximab and Belimumab for Lupus Nephritis — Completed